The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cyclooxygenase Inhibition Restores Nitric Oxide Activity in Essential Hypertension
Open accessAbstract
To evaluate whether cyclooxygenase constrictor substances can impair nitric oxide-mediated vasodilation in essential hypertension, in seven normotensive subjects (43.3±4.1 years; BP, 117±6/81±2 mm Hg) and seven essential hypertensive patients (47.1±5.2 years; BP, 151±8/98±4 mm Hg) we studied forearm blood flow (strain-gauge plethysmography) modifications induced by intrabrachial acetylcholine (0.15,0.45, 1.5, 4.5, 15 μg·100 mL −1 ·min −1 ) in basal conditions, during infusion of N G -monomethyl- l -arginine (L-NMMA; 100 μg·100 mL −1 ·min −1 ), a nitric oxide synthase inhibitor, or indomethacin (50 μg·100 mL −1 ·min −1 ), a cyclooxygenase inhibitor, or simultaneous indomethacin and L-NMMA. In normotensives, vasodilation to acetylcholine was blunted by L-NMMA (maximum flow increase: 671±64% and 386±42%, respectively; P <.01), and this effect was unchanged by indomethacin. In contrast, in hypertensive patients, vasodilation to acetylcholine (maximum flow increase: 458±33%) was unchanged by L-NMMA. Indomethacin significantly ( P <.01) increased the response to acetylcholine (maximum flow increase: 635±53%) and restored the inhibitory effect of L-NMMA (maximum flow increase: 445±36%; P <.01 versus indomethacin alone). In an adjunctive seven normotensives (51.4±4.2 years; BP, 114±5/79±3 mm Hg) and seven essential hypertensives (53.2±7.6 years; BP, 153±9/100±3 mm Hg) we repeated the same protocol by replacing L-NMMA with l -arginine (200 μg·100 mL −1 ·min −1 ), the substrate for NO synthase. In normotensives, vasodilation to acetylcholine was increased by l -arginine (maximum flow increase: 539±48% and 806±61%, respectively) and this effect was unchanged by indomethacin. In hypertensive patients, vasodilation to acetyl-choline (maximum flow increase: 339±32%) was unchanged by l -arginine but was significantly ( P <.01) increased by indomethacin (maximum flow increase: 592±38%). Moreover, indomethacin restored the facilitatory effect of l -arginine (maximum flow increase: 804±56%; P <.01 versus indomethacin alone). Therefore, cyclooxygenase inhibition restores nitric oxide-mediated vasodilation in essential hypertension, suggesting that cyclooxygenase-dependent substances can impair nitric oxide production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Cited by
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Vascular nitric oxide: Beyond eNOS
Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 826
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818
Endothelial dysfunction and vascular disease
Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Feletou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 806
Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A., & Salvetti, A. (1998) · Circulation · doi:10.1161/01.cir.97.22.2222 · Cited by 762
Self-citation
Metadata
- Authors
- Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A., & Salvetti, A.
- Venue
- Hypertension
- Published
- 1997-01
- Volume
- 29
- Issue
- 1
- Pages
- 274-279
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2118573949
- Cited by
- 206
- References
- 2
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.